Dovetail Genomics, a Scotts Valley, CA-based company providing genomic solutions, received a $2M SBIR Grant from the National Human Genome Research Institute (NHGRI).
The company intends to allocate the amount for additional development and validation of its recently launched LinkPrep™ technology in clinically relevant oncology sample types using an automated protocol and high-throughput analysis capabilities.
Led by CEO Matt Easterday, Dovetail Genomics, a subsidiary of Cantata Bio and an Edenroc Sciences company, is a provider of genomics solutions focused on understanding the complex organization of the genome. Through its proprietary proximity ligation technologies, the 3D architecture of the genome is captured alongside primary sequence information using standard sequencing (NGS) approaches. Researchers are using its methods to solve problems including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing, and microbiome analysis in the fields of epigenetics, developmental biology, cancer research, evolutionary biology and more.
FinSMEs
07/11/2024